ADVERTISEMENT

Ivermectin fails to deliver benefits in patients with mild or moderate COVID-19

Heather Mason   |   Medical News   |   26 October 2022
ADVERTISEMENT

Compared with placebo, ivermectin does not shorten symptom duration or prevent hospitalisation in patients with mild or moderate COVID-19, according to new research findings.

ACTIV-6 is an ongoing clinical trial designed to evaluate the effectiveness of repurposed drugs that are already approved for the treatment of other diseases but not...

          

January Challenge

Ends in 2d 14h
left
right

Topic Challenges

left
right